Coronavirus Notebook: EMA OKs Moderna’s Second Bivalent Spikevax, New Deal Agreed To Boost Vaccine R&D And Manufacturing
Executive Summary
The EU regulator has recommended extending the use of the mRNA COVID-19 vaccines to younger children, and EU ministers have formally endorsed two regulations intended to strengthen the response to the pandemic and future health emergencies, including through the joint procurement of vaccines.
You may also be interested in...
Stakeholders Gather To Discuss Pandemic Response And Next Steps
As Europe’s health emergency body HERA approaches its first anniversary, an unprecedented range of stakeholders including industry bodies will be meeting in December to discuss HERA’s achievements, while a separate event will showcase the next generation of vaccines for COVID-19 and other infections.
New EU Rules Imminent On Joint Procurement Of Vaccines & Drugs In Health Crises
EU legislation just approved by legislators will require the European Commission to provide information on prices, manufacturers, delivery time frames and joint procurement processes for vaccines and medicines used in tackling future health crises such as pandemics.
EU Review Proposals ‘Fail To Analyze’ Impact Of Reduced Exclusivity Periods
Plans for the overhaul of the EU’s medicines framework are missing key analysis on the effect of reductions in data and market protection on the pharmaceutical industry, despite an abundance of studies on how such incentives influence company decisions on whether to develop new products, say lawyers from Sidley.